
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sec15A CRISPR/Cas9 KO Plasmid (h) | sc-405860 | 20 µg | $397.00 |
EXOC6 encodes Sec15A, a core component of the octameric exocyst complex that mediates spatially regulated tethering of secretory vesicles to the plasma membrane prior to SNARE-dependent fusion. Sec15A helps couple RAB and RHO-family GTPase signaling to polarized exocytosis, supporting membrane protein delivery, cell migration, cytokinesis, and epithelial polarity. Through its role in vesicle trafficking and membrane remodeling, EXOC6 is relevant to pathways that shape cell–cell junctions and receptor recycling, processes frequently perturbed in proliferative and invasive cellular phenotypes. Dysregulation of exocyst subunits, including Sec15A, has been associated in the literature with altered secretion programs and signaling outputs in cancer-related and neurodevelopmental contexts, making EXOC6 a useful target for mechanistic studies.
Sec15A CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the EXOC6 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the EXOC6 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the EXOC6 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Sec15A protein expression.
This CRISPR knockout system enables efficient generation of EXOC6-deficient cell models for investigation of Sec15A signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.